Citation Impact
Citing Papers
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
2012
Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
2008
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
2018
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
2010
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer Statistics, 2021
2021 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma
2013
EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies
2011
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Non-animal models in dermatological research
2018
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
A guide to immunometabolism for immunologists
2016 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Cancer drug resistance: an evolving paradigm
2013 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Memory T cells need CD28 costimulation to remember
2009
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
2011
EGF–ERBB signalling: towards the systems level
2006 Standout
Sex differences in cancer mechanisms
2020
Molecular mechanisms of cisplatin resistance
2011 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells
2007
Combined autophagy and proteasome inhibition
2014
Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation
2008
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy
2011
Preventing Allograft Rejection by Targeting Immune Metabolism
2015
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
2015
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
2010 StandoutNobel
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
2016
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
2008
Targeting autophagy in cancer
2017 Standout
Emerging drugs for non-small-cell lung cancer
2007
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
2017
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
2017
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Gastrointestinal toxicities of novel agents in cancer therapy
2009
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
2013
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance
2007
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group
2013
Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial
2012
Head and Neck Cancer
2020 Standout
Nanoparticle Delivery of Pooled siRNA for Effective Treatment of Non-Small Cell Lung Caner
2012
Incorporating Bortezomib into the Treatment of Lung Cancer
2007
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
2007
Antigen‐Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal‐Immunotherapy
2018
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives
2015
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
The global burden of lung cancer: current status and future trends
2023
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
American Cancer Society's report on the status of cancer disparities in the United States, 2021
2021
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Lysyl Oxidase: From Basic Science to Future Cancer Treatment
2012
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
2010
Works of Luis E. Raez being referenced
Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
2011
Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?
2018
Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art
2010
Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
2010
A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung
2010
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
2014
Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature
2006
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies
2017
Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer
2010
A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
2012
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation
2009
Heat Shock Protein–Based Cancer Vaccines
2006
New targets for non-small-cell lung cancer therapy
2007
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments
2018
Induction of CD8 T-cell-Ifn-γ response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma
2003
Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation
2014
The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
2017
Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer
2004
Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial
2013
Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy
2020
DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN).
2012
EGFR Targeting of Solid Tumors
2007
BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
2013
Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer
2006
Chemotherapy in advanced non-small cell lung cancer
1991
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.
2014
Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma
2006